Tehran Chemie History
Tehran Chemie Pharmaceutical Company, one of Iran’s leading pharmaceutical companies, was founded in Khordad 1335 (Solar Hijri) by Dr. Abdollah Rezaei and his brothers. The company initially engaged in the importation of pharmaceuticals; however, from the very beginning, it contemplated establishing a pharmaceutical unit in Iran. In a relatively short period, with the collaboration of two major German pharmaceutical centers—“Boehringer Mannheim” and “Chemie Grünenthal”—as partners, collaborators, and scientific supporters, Tehran Chemie began offering pharmaceutical products. By adding to and equipping the plant with the most modern automatic and semi-automatic machinery, as well as quality control laboratories and a control warehouse, … adjacent to the factory, it continued to expand its activities in order to meet the needs of the nation’s healthcare sector. In Azar 1344, with accelerating growth, Tehran Chemie multiplied its capital several times over to expand its operations and increased its workforce to more than 110 Iranian and foreign specialists, with Iranians constituting the majority of shareholders and employees across various departments. This upward trajectory has continued over time, with a legacy and authenticity as enduring as Iran’s pharmaceutical industry. Today, Tehran Chemie continues to move forward by employing the most modern technologies and tools, and with the presence of more than 400 committed and specialized personnel, to provide a diverse range of pharmaceutical products. It is a matter of pride that Tehran Chemie, with continuous advancement, has consistently delivered a worthy and commendable performance among the top manufacturing companies in Iran’s pharmaceutical industry in the production of generic products. With more than 60 years of history, it continues to proceed on its path with distinction and innovation, adding to its legacy and authenticity.
Board Members
Policy
Tehran Chemie Pharmaceutical Company (Public Joint Stock), specialized in the development, production, and marketing of generic and proprietary medicines as well as pharmaceutical raw materials, in order to align its operations with its mission and strategic trajectory, and with a continual improvement approach to processes and product manufacturing aimed at increasing customer satisfaction, while understanding the needs and expectations of interested parties, has established an Integrated Management System (IMS) based on the requirements of ISO 9001:2015, ISO 45001:2018, and ISO 140001:2015 and, while adhering to the principles of Good Manufacturing Practices (GMP), always considers the following values:
Implementing a risk and opportunity management approach and planning changes commensurate with the potential impact on product conformity with requirements.
Commitment to preventing and reducing environmental pollution.
Commitment to eliminating hazards and reducing risk to create a safe environment and prevent injury and illness.
Creating mutual trust in mutually beneficial two-way relationships with suppliers.
Determining, developing, maintaining, and sharing the knowledge essential for the execution of processes.
Providing resources, their optimal utilization, and waste management.
The company’s integrated policy is accessible and has been communicated within the organization, and it is reviewed at various intervals to evaluate its adequacy and conformity with the organization’s requirements and objectives. The employees of this company apply their capabilities to ensure committed participation, adherence to requirements, and the utilization of improvement opportunities.
Organizational Values
The managers and employees of Tehran Chemie Pharmaceutical Company (Public Joint Stock), while making purposeful and continuous efforts to achieve common and lofty organizational goals, observe the following individual and organizational values:
Honesty in speech, transparency in performance, and adherence to fair and professional ethics
Promoting a synergy-oriented and integrated mindset and the development of knowledge while preserving human dignity and respect
Commitment to the dimensions of social responsibility toward society, customers, the environment, and other stakeholders
Diligence in observing the requirements of Good Manufacturing Practices (GMP) and the standards of the Integrated Management System (IMS)
Vision and Mission of the Organization
Tehran Chemie Pharmaceutical Company (Public Joint Stock) seeks, while preserving and enhancing its commercial reputation and organizational pursuit of excellence, and in line with the development of research and production in accordance with modern global methods and state-of-the-art technology as well as effective presence in international markets, to attain a position among the first to third ranks of the Iranian pharmaceutical market and to become a prominent brand in regional markets.
Tehran Chemie Pharmaceutical Company (Public Joint Stock), with more than half a century of distinguished activity, as one of the leading companies in the country’s health and hygiene system, produces generic and proprietary medicines across various therapeutic categories, and in this path, while benefiting from the latest scientific achievements and state-of-the-art technology and committing to the implementation and enhancement of modern management systems and standards that promote quality and continuous improvement, operates with the objectives of achieving self-sufficiency in the national pharmaceutical industry, contributing to the improvement of public health, increasing the domestic market share of medicines, and also entering foreign markets and exports.
Awards
-
1397 ، تندیس بانک صادراتدریافت تندیس یادبود با عنوان همایش مشتریان برتر بانک صادرات -
1396، رتبه زرین کارت بازرگانیدریافت گواهی نامه رتبه زرین یک ستاره از مرکز ملی رتبه بندی ایران با امتیاز 81.03 از 100 امتیاز به نمایندگی به مدیر عامل تهران شیمی جناب آقای دکتر علی مهرآمیزی اعطاء گردید.
-
1394، جایزه تولید کنندگان پیشتاز سازمان غذا و داروتقدیر از شرکت داروسازی تهران شیمی ( بخش تولید کنندگان پیشتاز) در رابطه با تولید داروی آکورا (تترابنازین)
-
1391، اشتهار به کیفیت داروی ضد دیابتمدیر عامل تهران شیمی جناب آقای دکتر علی مهرآمیزی، موفق به دریافت تقدیر نامه اشتهارد به کیفیت محصولات از طرف سازمان غذا و دارو شدند. این تقدیر نامه در بخش دارویی و به جهت مدیریت تولید داروی ضد دیابت اعطاء گشت.
-
1391، اشتهار به کیفیت داروی ضد چربی خونمدیر عامل تهران شیمی جناب آقای دکتر علی مهرآمیزی، موفق به دریافت تقدیر نامه اشتهارد به کیفیت محصولات از طرف سازمان غذا و دارو شدند. این تقدیر نامه در بخش دارویی و به جهت مدیریت تولید داروی ضد چربی خون اعطاء گشت.
-
1391، رتبه سیمین کارت بازرگانیگواهینامه رتبه سیمین در طرح ملی رتبه بندی کارت های بازرگانی به نمایندگی به جناب آقای دکتر علی مهرآمیزی مدیر عامل تهران شیمی اهداء گشت.
-
1390، اهتمام به کیفیت آزیترومایسین جامددر دومین دوره برگزاری جایزه ملی کیفیت غذا و دارو که در سال 1390 به همت معاونت غذا و داروی وزارت بهداشت صورت گرفت، شرکت داروسازی تهران شیمی موفق به اخذ گواهی نامه اهتمام به کیفیت برای محصول آزیترومایسین به شکل جامد شد.
-
1390 – 1386، جشنواره ملی بهره وریدر چهارمین جشنواره ملی بهره وری، بر اساس محاسبات صورت گرفته توسط سامانه ملی اندازه گیری شاخص های بهره وری، شرکت تهران شیمی موفق به دریافت گواهی نامه جهت عملکرد مناسب در گروه مواد و محصولات دارویی طی سال های 86 – 90 بوده است.
-
1382، لوح تقدیر از وزارت صنایع و معادنبه پاس تلاش و کوشش کارکنان تهران شیمی به خصوص مدیر عامل محترم و کارکنان شایسته در بخش تحقیق و توسعه در موفقیت، جهت تولید قرص روکشدار کلاریترومایسین 250 میلی گرمی، این لوح به امضای وزیر صنعت و معدن در سال 1382 جناب آقای اسحاق جهانگیری، به تهران شیمی اهداء شد.
Quality Control
The first and most important duty of pharmaceutical manufacturers is to ensure the efficacy of their products, and this is only achieved through rigorous and continuous quality control methods. The Quality Control Department of Tehran Chemie Pharmaceutical Company, in a space measuring 700 square meters, with experienced management and the support of its skilled personnel, and using modern equipment in accordance with the latest FDA quality control guidelines and international standards, is fully committed to the qualitative evaluation of manufactured products. This department comprises three laboratories—Microbiological Control, Physical and Chemical Control, and In-Process Control—which together employ 42 specialists with bachelor’s, master’s, and doctoral degrees, working across various sections including instrumental analysis, microbiology, IPQC, packaging material control, and physicochemical control of raw materials and finished products.
The laboratories of this department are equipped with HPLC, GC, TOC, Particle Counter, NIR, FTIR, and spectrophotometer devices, and with the use of this advanced equipment operate in the areas of raw material controls, packaging items, stability studies, PMQC, and the quality control of the factory’s process water.
The Documentation and Validation section of the Quality Control Laboratory is responsible for standardizing test methods and updating the related procedures based on the latest editions of the sources.
The Quality Control Department of the pharmaceutical company, by virtue of its appropriate facilities, advanced and well-equipped instruments, and specialized and experienced personnel, has obtained an operating license for an authorized laboratory from the Food and Drug Administration of the Ministry of Health and Medical Education, and is recognized as an authorized pharmaceutical laboratory. Continuous, effective oversight and control is the motto of the Quality Control Department, and adherence to it has led to the excellence of Tehran Chemie Pharmaceutical Company’s products.
